Truist Securities reiterates Sell rating on Phreesia stock with $36 price target

Phreesia Inc. (NYSE:PHR) reported its first positive net income in Q2 FY26, exceeding revenue forecasts, and announced a $160 million acquisition of AccessOne, projected to add $35 million in annual revenue. Despite these strong results and strategic M&A, Truist Securities maintained a Sell rating, albeit raising its price target to $36 based on updated FY26/27 EBITDA estimates that notably exclude the AccessOne contribution. This contrasts sharply with other analysts, including Raymond James, Canaccord Genuity, and Needham, who raised price targets, and DA Davidson, which initiated Buy coverage, all citing Phreesia's robust performance and the strategic acquisition as key catalysts.

Analysis

Phreesia Inc. (PHR) has demonstrated significant fundamental improvement and strategic execution, reporting its first positive net income in Q2 FY26 with an EPS of $0.01, starkly outperforming the forecasted loss of $0.06. This was accompanied by a 15% year-over-year revenue increase to $117.3 million, surpassing estimates. The company is augmenting this organic growth with the $160 million acquisition of AccessOne, a move expected to be accretive, contributing an estimated $35 million in annual revenue and $11 million in EBITDA post-finalization. This has prompted a wave of positive analyst revisions, with Canaccord Genuity, Raymond James, and Needham all raising price targets to $38, $33, and $35 respectively, and DA Davidson initiating with a Buy rating. In sharp contrast, Truist Securities maintained its Sell rating, despite raising its price target to $36 from $35. Truist's valuation is notably conservative, based on a 16x multiple of its CY2027 adjusted EBITDA estimate and, critically, their financial projections explicitly exclude any contribution from the AccessOne acquisition. This outlier stance suggests a valuation disconnect, as the rest of the analyst community is pricing in the positive impact of both the strong quarterly performance and the M&A activity.

Key Decisions for Investors

• Investors should weigh the significant divergence between Truist's Sell rating, which is based on projections excluding the accretive AccessOne acquisition, against the broad bullish consensus from other analysts who view the M&A and strong earnings as key positive catalysts.
• Given the company's first-ever quarterly profit, strong revenue growth, and an accretive acquisition expanding its TAM, the current price of $28.16 may present a buying opportunity for those aligned with the majority of analysts, as it trades well below most updated price targets.
• Monitor the execution and integration of the AccessOne acquisition closely, as its successful contribution to revenue and EBITDA will be critical to validating the bullish theses and potentially forcing a re-evaluation from more cautious observers.